AbbVie's FY2024 results demonstrated impressive recovery from the Humira biosimilar erosion crisis: while Humira revenues fell to USD 9.0 billion (from a USD 21 billion peak), the combination of Skyrizi (+51% to USD 11.7 billion) and Rinvoq (+25% to USD 6.0 billion) drove overall top-line growth
requires screening and monitoring Lifestyle + medical coaching What it is: Nutrition, movement, sleep, and behavior supports Primary effect: Foundation (improves consistency and maintenance) Evidence for weight loss: Strong What to know: Makes every other option work better and supports long-term results Important safety note on online GLP-1s: If youre considering semaglutide/tirzepatide, avoid sketchy sources and dosing confusion
Peptide therapy is integrated with personalised nutrition, physiotherapy and lifestyle optimisation to support tissue regeneration, reduce inflammation and prevent recurrence
Membership Value Founding members receive preferred pricing on advanced therapies, recovery services, diagnostics, and ongoing clinical support
